drugset / Trial / NCT02254655

The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis

NCT02254655

Phase 2 Completed 119 enrolled Chengdu PLA General Hospital
RandomizedParallel-groupSingle-blindSupportive care

Summary

The purpose of this study is to access the effect (week 12/week 24) of puerarin injection on carotid intima-media thickness (CIMT) in rheumatoid arthritis (RA) patients despite routine anti-rheumatic treatment.

Timeline

Start
2013-11
Primary completion
2017-09
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Puerarin Small molecule 400 mg Intravenous

Indications